Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Jacqueline A. French, John A. Lawson, Hiroko Ikeda, +10

The Lancet

HLA-B Locus in Japanese Patients with Anti-Epileptics and Allopurinol-Related Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara, +16

Pharmacogenomics

Light quality affects flavonoid biosynthesis in young berries of Cabernet Sauvignon grape

Kazuya Koyama, Hiroko Ikeda, Puspa Raj Poudel, +1

Phytochemistry

Light QualityBiosynthesisEngineeringCarotenoidBotany +5

<i>HLA‐B*1511</i> is a risk factor for carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara, +15

Epilepsia

A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Masahiro Tohkin, Nahoko Kaniwa, Yoshiro Saito, +15

The Pharmacogenomics Journal

Toxic Epidermal NecrolysisWhole-genome Association StudyGenetic EpidemiologyPathologyDermatology +5

PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps—an <scp>ILAE PNES</scp> Task Force report

Kousuke Kanemoto, W. Curt LaFrance, Roderick Duncan, +11

Epilepsia Open

NeuropsychologyNeurological DisorderDisabilityDiagnosisNeuropsychiatry +17

HLA Class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions

Hiroko Ikeda, Yukitoshi Takahashi, Etsuko Yamazaki, +6

Epilepsia

HistocompatibilityHlaImmunologyPharmacotherapyDermatology +17

<i>STXBP1</i> mutations cause not only Ohtahara syndrome but also West syndrome—Result of Japanese cohort study

Motoko Otsuka, Hirokazu Oguni, Jao‐Shwann Liang, +8

Epilepsia

Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial

Paolo Curatolo, David Neal Franz, John A. Lawson, +10

The Lancet Child & Adolescent Health

Tuberous Sclerosis ComplexPediatricsAdjunctive EverolimusNeurologyMultiple Sclerosis +2

Everolimus for treatment-refractory seizures in TSC

David Neal Franz, John A. Lawson, Hiroko Ikeda, +112

Neurology Clinical Practice